Reduced DPP4 activity improves insulin signaling in primary human adipocytes

Biochemical and Biophysical Research Communications

Volumn 471, Issue 3, 2016, Pages 348-354

  Röhrborn, Diana ^a   Brückner, Julia ^a   Sell, Henrike ^a   Eckel, Jürgen ^a  

^a LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

Author keywords

DPP4; DPP4 inhibition; Insulin signaling; Primary human adipocytes; siRNA mediated silencing

Indexed keywords

DIPEPTIDYL PEPTIDASE IV; INSULIN; PROTEIN KINASE B; SAXAGLIPTIN; SITAGLIPTIN; SMALL INTERFERING RNA; ADAMANTANE; ANTIDIABETIC AGENT; DIPEPTIDE; DIPEPTIDYL PEPTIDASE IV INHIBITOR; DPP4 PROTEIN, HUMAN;

ADIPOCYTE; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME SUBSTRATE; FEMALE; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; INSULIN RESISTANCE; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; ANALOGS AND DERIVATIVES; CELL CULTURE; CYTOLOGY; ENZYME ACTIVATION; METABOLISM; PHYSIOLOGY;

ADAMANTANE; ADIPOCYTES; CELL DIFFERENTIATION; CELLS, CULTURED; DIPEPTIDES; DIPEPTIDYL PEPTIDASE 4; DIPEPTIDYL-PEPTIDASE IV INHIBITORS; ENZYME ACTIVATION; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; SIGNAL TRANSDUCTION; SITAGLIPTIN PHOSPHATE;

EID: 84958922746     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2016.02.019     Document Type: Article

References (24)

1. T. Romacho, M. Elsen, D. Rohrborn, and J. Eckel Adipose tissue and its role in organ crosstalk Acta Physiol. (Oxf) 210 4 2014 733 753
2. V.K. Hopsu-Havu, and G.G. Glenner A new dipeptide naphthylamidase hydrolyzing glycyl-prolyl-beta-naphthylamide Histochemie 7 3 1966 197 201
3. H.J. Mest, and R. Mentlein Dipeptidyl peptidase inhibitors as new drugs for the treatment of type 2 diabetes Diabetologia 48 4 2005 616 620
4. R. Mentlein Dipeptidyl-peptidase IV (CD26)-role in the inactivation of regulatory peptides Regul. Pept. 85 1999 9 24
5. A.M. Lambeir, C. Durinx, S. Scharpe, and M.I. De Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV Crit. Rev. Clin. Lab. Sci. 40 2003 209 294
6. E.E. Mulvihill, and D.J. Drucker Pharmacology, physiology, and mechanisms of action of dipeptidyl peptidase-4 inhibitors Endocr. Rev. 35 6 2014 992 1019
7. O.J. Cordero, F.J. Salgado, and M. Nogueira On the origin of serum CD26 and its altered concentration in cancer patients Cancer Immunol. Immunother. 58 2009 1723 1747
8. N. Wronkowitz, S.W. Gorgens, T. Romacho, L.A. Villalobos, C.F. Sanchez-Ferrer, C. Peiro, H. Sell, and J. Eckel Soluble DPP4 induces inflammation and proliferation of human smooth muscle cells via protease-activated receptor 2 Biochim. Biophys. Acta 1842 2014 1613 1621
9. D. Rohrborn, J. Eckel, and H. Sell Shedding of dipeptidyl peptidase 4 is mediated by metalloproteases and up-regulated by hypoxia in human adipocytes and smooth muscle cells FEBS Lett. 588 2014 3870 3877
10. D. Lamers, S. Famulla, N. Wronkowitz, S. Hartwig, S. Lehr, D.M. Ouwens, K. Eckardt, J.M. Kaufman, M. Ryden, S. Muller, F.G. Hanisch, J. Ruige, P. Arner, H. Sell, and J. Eckel Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome Diabetes 60 2011 1917 1925
11. H. Sell, M. Bluher, N. Kloting, R. Schlich, M. Willems, F. Ruppe, W.T. Knoefel, A. Dietrich, B.A. Fielding, P. Arner, K.N. Frayn, and J. Eckel Adipose dipeptidyl peptidase-4 and obesity: correlation with insulin resistance and depot-specific release from adipose tissue in vivo and in vitro Diabetes Care 36 2013 4083 4090
12. D. Dietze-Schroeder, H. Sell, M. Uhlig, M. Koenen, and J. Eckel Autocrine action of adiponectin on human fat cells prevents the release of insulin resistance-inducing factors Diabetes 54 7 2005 2003 2011
13. T. Skurk, S. Ecklebe, and H. Hauner A novel technique to propagate primary human preadipocytes without loss of differentiation capacity Obes. (Silver Spring) 15 12 2007 2925 2931
14. J. Rosmaninho-Salgado, A.P. Marques, M. Estrada, M. Santana, V. Cortez, E. Grouzmann, and C. Cavadas Dipeptidyl-peptidase-IV by cleaving neuropeptide Y induces lipid accumulation and PPAR-gamma expression Peptides 37 2012 49 54
15. A.D. Dobrian, Q. Ma, J.W. Lindsay, K.A. Leone, K. Ma, J. Coben, E.V. Galkina, and J.L. Nadler Dipeptidyl peptidase IV inhibitor sitagliptin reduces local inflammation in adipose tissue and in pancreatic islets of obese mice Am. J. Physiol. Endocrinol. Metab. 300 2 2011 E410 E421
16. K. Miyagawa, T. Kondo, R. Goto, R. Matsuyama, K. Ono, S. Kitano, S. Kawasaki, M. Igata, J. Kawashima, T. Matsumura, H. Motoshima, and E. Araki Effects of combination therapy with vildagliptin and valsartan in a mouse model of type 2 diabetes Cardiovasc Diabetol. 12 1 2013 1 14
17. T. Ikeda, E. Kumagai, S. Iwata, and A. Yamakawa Soluble CD26/Dipeptidyl Peptidase IV Enhances the Transcription of IL-6 and TNF-alpha in THP-1 Cells and Monocytes PLoS One 8 2013 e66520
18. T. Shinjo, Y. Nakatsu, M. Iwashita, T. Sano, H. Sakoda, H. Ishihara, A. Kushiyama, M. Fujishiro, T. Fukushima, Y. Tsuchiya, H. Kamata, F. Nishimura, and T. Asano DPP-4 inhibitor anagliptin exerts anti-inflammatory effects on macrophages, adipocytes, and mouse livers by suppressing NF-kappaB activation Diabetol. Metab. Syndr. 7 1 2015 1 6
19. A. Makdissi, H. Ghanim, M. Vora, K. Green, S. Abuaysheh, A. Chaudhuri, S. Dhindsa, and P. Dandona Sitagliptin exerts an antiinflammatory action J. Clin. Endocrinol. Metab. 97 9 2012 3333 3341
20. E. Carvalho, P.A. Jansson, M. Axelsen, J.W. Eriksson, X. Huang, L. Groop, C. Rondinone, L. Sjostrom, and U. Smith Low cellular IRS 1 gene and protein expression predict insulin resistance and NIDDM FASEB J. 13 15 1999 2173 2178
21. P.R. Srinivas, A.S. Wagner, L.V. Reddy, D.D. Deutsch, M.A. Leon, A.S. Goustin, and G. Grunberger Serum alpha 2-HS-glycoprotein is an inhibitor of the human insulin receptor at the tyrosine kinase level Mol. Endocrinol. 7 11 1993 1445 1455
22. J.F. Youngren Regulation of insulin receptor function Cell Mol. Life Sci. 64 7-8 2007 873 891
23. S. Ussar, O. Bezy, M. Bluher, and C.R. Kahn Glypican-4 enhances insulin signaling via interaction with the insulin receptor and serves as a novel adipokine Diabetes 61 9 2012 2289 2298
24. G.A. Piazza, H.M. Callanan, J. Mowery, and D.C. Hixson Evidence for a role of dipeptidyl peptidase IV in fibronectin-mediated interactions of hepatocytes with extracellular matrix Biochem. J. 262 1989 327 334